News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
WHEELER KURT
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/11/2019 |
4
| WHEELER KURT (Director) has filed a Form 4 on GLOBUS MEDICAL INC|
Txns:
| Granted 25,000 options to buy
@ $43.58, valued at
$1.1M
|
|
| 10/02/2018 |
4
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Converted 361,829 shares
@ $0
Converted 323,341 shares
@ $0
Converted 412,583 shares
@ $0
Bought 453,395 shares
@ $15, valued at
$6.8M
Converted 7,500,000 convertible preferred
@ $0
Converted 6,702,213 options to buy
@ $0
Converted 8,552,024 options to buy
@ $0 |
|
| 09/25/2018 |
3
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 3 on Entasis Therapeutics Holdings Inc. |
| 07/02/2018 |
4
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Converted 938,489 shares
@ $0
Converted 755,780 shares
@ $0
Converted 1,922,682 shares
@ $0
Bought 200,000 shares
@ $16, valued at
$3.2M
Converted 938,489 preferred shares
@ $0
Converted 755,780 preferred shares
@ $0
Converted 1,922,682 preferred shares
@ $0 |
|
| 06/27/2018 |
3
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 3 on Forty Seven, Inc. |
| 01/24/2018 |
4
| WHEELER KURT (Director) has filed a Form 4 on GLOBUS MEDICAL INC|
Txns:
| Granted 25,000 options to buy
@ $43.77, valued at
$1.1M
|
|
| 10/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/01/2017 |
4
| WHEELER KURT (Director) has filed a Form 4 on GLOBUS MEDICAL INC|
Txns:
| Granted 25,000 options to buy
@ $26.27, valued at
$656.8k
|
|
| 09/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/10/2016 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Sold 103,123 shares
@ $0.19, valued at
$19.6k
Sold 230,507 shares
@ $0.16, valued at
$36.9k
|
|
| 02/09/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 02/05/2016 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Sold 82,583 shares
@ $0.15, valued at
$12.4k
Sold 500,026 shares
@ $0.14, valued at
$70k
Sold 832,881 shares
@ $0.2, valued at
$166.6k
|
|
| 02/02/2016 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP |
| 01/28/2016 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP |
| 01/27/2016 |
4
| WHEELER KURT (Director) has filed a Form 4 on GLOBUS MEDICAL INC|
Txns:
| Granted 20,000 options to buy
@ $25.52, valued at
$510.4k
|
|
| 01/06/2016 |
4
| WHEELER KURT (Director) has filed a Form 4 on GLOBUS MEDICAL INC|
Txns:
| Sold 255 shares
@ $27.5, valued at
$7k
Sold 15,045 shares
@ $27.5, valued at
$413.7k
Exercised 255 options to buy
@ $15.34, valued at
$3.9k
Exercised 15,045 options to buy
@ $15.34, valued at
$230.8k
|
|
| 06/17/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 1,529 shares
@ $14.27, valued at
$21.8k
Sold 39,701 shares
@ $14.3, valued at
$567.7k
|
|
| 06/12/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 25,168 shares
@ $14.27, valued at
$359.1k
Sold 6,430 shares
@ $14.25, valued at
$91.6k
|
|
| 06/10/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 2,662 shares
@ $14.25, valued at
$37.9k
Sold 13,000 shares
@ $14.26, valued at
$185.4k
Sold 8,987 shares
@ $14.32, valued at
$128.7k
|
|
| 06/03/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 15,010 shares
@ $14.29, valued at
$214.5k
Sold 11,014 shares
@ $14.25, valued at
$156.9k
Sold 10,450 shares
@ $14.32, valued at
$149.6k
|
|
| 05/28/2015 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on Ophthotech Corp. |
| 03/24/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 27,115 shares
@ $14.53, valued at
$394k
Sold 26,300 shares
@ $14.44, valued at
$379.8k
|
|
| 03/19/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 79,307 shares
@ $14.67, valued at
$1.2M
Sold 25,000 shares
@ $14.68, valued at
$367k
Sold 50,012 shares
@ $14.61, valued at
$730.7k
|
|
| 01/30/2015 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC |
| 01/30/2015 |
4/A
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC |
| 01/22/2015 |
4
| WHEELER KURT (Director) has filed a Form 4 on GLOBUS MEDICAL INC|
Txns:
| Granted 15,000 options to buy
@ $24.1, valued at
$361.5k
|
|
| 01/12/2015 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC |
| 01/06/2015 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC |
| 12/30/2014 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC |
| 12/24/2014 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC |
| 06/16/2014 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC |
| 06/11/2014 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on Ophthotech Corp. |
|
|
|